Bio-Connect
IHC-P analysis of human brain tissue using GTX85036 CAPS1 antibody. Working concentration : 5 microg/ml
IHC-P analysis of human brain tissue using GTX85036 CAPS1 antibody. Working concentration : 5 microg/ml
IHC-P analysis of human brain tissue using GTX85036 CAPS1 antibody. Working concentration : 5 microg/ml

CAPS1 antibody

GTX85036
GeneTex
TargetCADPS
Product group Antibodies
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    CAPS1 antibody
  • Delivery Days Customer
    9
  • Antibody Specificity
    Numerous isoforms of CAPS1 are known to exist. This CAPS1 antibody is predicted to be specific to CAPS1 and not recognize CAPS2.
  • Application Supplier Note
    WB: 0.5 microg/mL. IHC-P: 5 microg/mL. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Concentration
    1 mg/ml
  • Formulation
    Liquid
  • Gene ID8618
  • Target name
    CADPS
  • Target description
    calcium dependent secretion activator
  • Target synonyms
    Ca++-dependent secretion activator; Ca2+ dependent secretion activator; Ca2+-dependent activator protein for secretion; Ca2+-regulated cytoskeletal protein; CADPS1; calcium-dependent activator protein for secretion 1; calcium-dependent secretion activator 1; CAPS; CAPS1; CAPS-1; UNC-31
  • Protein IDQ9ULU8
  • Protein Name
    Calcium-dependent secretion activator 1
  • Scientific Description
    CAPS1 and its related protein CAPS2 encode novel neural/endocrine-specific cytosolic and peripheral membrane proteins. Both are essential components of the synaptic vesicle priming machinery and are required for the Ca2+-regulated exocytosis of secretory vesicles; CAPS-deficienct neurons contain no or very few fusion competent synaptic vesicles, causing a selective impairment of fast phasic transmitter release. CAPS1 acts at a stage in exocytosis that follows ATP-dependent priming, which involves the essential synthesis of phosphatidylinositol 4,5-bisphosphate and is thought to be a specific regulator of large dense-core vesicle fusion. Numerous isoforms of CAPS1 are known to exist. This CAPS1 antibody is predicted to be specific to CAPS1 and not recognize CAPS2.
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203